The Valley Desk

NCT01974752 · Interventional trial

Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)

Overall registry status Completed

Phase 3

Conditions Metastatic, Uveal Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov